Natural History of Venous Thromboembolism

Critical Care Clinics

Volumn 27, Issue 4, 2011, Pages 869-884

  Morris, Timothy A ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Chronic thromboembolic pulmonary hypertension; Chronic thrombotic venous disease; Deep venous thrombosis; Pulmonary embolism; Venous thromboembolism

Indexed keywords

ANTITHROMBIN III; FIBRINOLYTIC AGENT; HEPARIN; PROTEIN C; PROTEIN S;

ARTIFICIAL EMBOLISM; BLOOD CLOTTING; BLOOD VESSEL OCCLUSION; CHRONIC DISEASE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; DEEP VEIN THROMBOSIS; FIBRINOLYSIS; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART OUTPUT; HEMODYNAMIC PARAMETERS; HUMAN; HYPERVENTILATION; LUNG ARTERY PRESSURE; LUNG EMBOLISM; LUNG PERFUSION; LUNG PRESSURE; LUNG VENTILATION PERFUSION RATIO; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECURRENCE RISK; REVIEW; THROMBOPHILIA; VASCULAR RESISTANCE; VENOUS STASIS; VENOUS THROMBOEMBOLISM;

CHRONIC DISEASE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; PLASMINOGEN ACTIVATORS; PULMONARY EMBOLISM; RESPIRATION; VENOUS THROMBOSIS; VENTILATION-PERFUSION RATIO;

EID: 82755162090     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2011.09.001     Document Type: Review

References (121)

1. Bagot C.N., Arya R. Virchow and his triad: a question of attribution. Br J Haematol 2008, 143:180-190.
2. Lowe G.D. Virchow's triad revisited: abnormal flow. Pathophysiol Haemost Thromb 2003, 33:455-457.
3. Christen Y., Wutschert R., Weimer D., et al. Effects of intermittent pneumatic compression on venous haemodynamics and fibrinolytic activity. Blood Coagul Fibrinolysis 1997, 8:185-190.
4. Hull R.D., Raskob G.E., Gent M., et al. Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement [see comments]. JAMA 1990, 263:2313-2317.
5. Woolson S.T., Watt J.M. Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. J Bone Joint Surg [Am] 1991, 73:507-512.
6. Belcaro G., Geroulakos G., Nicolaides A.N., et al. Venous thromboembolism from air travel: the LONFLIT study. Angiology 2001, 52:369-374.
7. Wolf L.D., Hozack W.J., Rothman R.H. Pulmonary embolism in total joint arthroplasty. Clin Orthop Relat Res 1993, 288:219-233.
8. Planaes A., Vochelle N., Fafola M. Venous thromboembolic prophylaxis in orthopedic surgery: knee surgery. Semin Thromb Hemost 1999, 25(Suppl 3):73-77.
9. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th edition). Chest 2008, 133:381S-453S.
10. Koster T., Rosendaal F.R., de Ronde H., et al. Venous thrombosis due to poor anticoagulant response to activated protein C: leiden thrombophilia study. Lancet 1993, 342:1503-1506.
11. Poort S.R., Rosendaal F.R., Reitsma P.H., et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996, 88:3698-3703.
12. Kearon C. Natural history of venous thromboembolism. Circulation 2003, 107:I22-I30.
13. Prandoni P., Cogo A., Bernardi E., et al. A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. Circulation 1993, 88:1730-1735.
14. Prandoni P., Lensing A.W., Cogo A., et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996, 125:1-7.
15. Prandoni P., Villalta S., Bagatella P., et al. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica 1997, 82:423-428.
16. Wagenvoort C.A. Pathology of pulmonary thromboembolism. Chest 1995, 107:10S-17S.
17. Landaw S.A. Homeostasis, survival, and red cell kinetics: measurement and imaging of red cell production. Hematology: basic principles and practice 1995, 274-290. Churchill Livingston, New York. R. Hoffman, E.J. Benz, S.J. Shattil (Eds.).
18. Franco R.S. The measurement and importance of red cell survival. Am J Hematol 2008, 84:109-114.
19. Kuruvilla J., Wells P.S., Morrow B., et al. Prospective assessment of the natural history of positive d-dimer results in persons with acute venous thromboembolism (DVT or PE). Thromb Haemost 2003, 89:284-287.
20. Prandoni P., Lensing A.W., Prins M.H., et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002, 137:955-960.
21. van Ramshorst B., van Bemmelen P.S., Hoeneveld H., et al. Thrombus regression in deep venous thrombosis. Quantification of spontaneous thrombolysis with duplex scanning. Circulation 1992, 86:414-419.
22. Pengo V., Lensing A.W., Prins M.H., et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004, 350:2257-2264.
23. Skoro-Sajer N., Becherer A., Klepetko W., et al. Longitudinal analysis of perfusion lung scintigrams of patients with unoperated chronic thromboembolic pulmonary hypertension. Thromb Haemost 2004, 92:201-207.
24. Labropoulos N., Patel P.J., Tiongson J.E., et al. Patterns of venous reflux and obstruction in patients with skin damage due to chronic venous disease. Vasc Endovasc Surg 2007, 41:33-40.
25. Labropoulos N., Tiongson J., Pryor L., et al. Definition of venous reflux in lower-extremity veins. J Vasc Surg 2003, 38:793-798.
26. Kahn S.R., Ginsberg J.S. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 2004, 164:17-26.
27. Kahn S.R., Shrier I., Julian J.A., et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008, 149:698-707.
28. Fedullo P.F., Auger W.R., Kerr K.M., et al. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001, 345:1465-1472.
29. Wille-Jorgensen P., Jorgensen T., Andersen M., et al. Postphlebitic syndrome and general surgery: an epidemiologic investigation. Angiology 1991, 42:397-403.
30. Biguzzi E., Mozzi E., Alatri A., et al. The post-thrombotic syndrome in young women: retrospective evaluation of prognostic factors. Thromb Haemost 1998, 80:575-577.
31. Sevitt S., Gallagher N. Venous thrombosis and pulmonary embolism. A clinico-pathological study in injured and burned patients. Br J Surg 1961, 48:475-489.
32. Prandoni P., Bernardi E. Upper extremity deep vein thrombosis. Curr Opin Pulm Med 1999, 5:222-226.
33. Hingorani A., Ascher E., Hanson J., et al. Upper extremity versus lower extremity deep venous thrombosis. Am J Surg 1997, 174:214-217.
34. Moser K.M., LeMoine J.R. Is embolic risk conditioned by location of deep venous thrombosis?. Ann Intern Med 1981, 94:439-444.
35. Huisman M.V., Buller H.R., ten Cate J.W. Utility of impedance plethysmography in the diagnosis of recurrent deep-vein thrombosis. Arch Intern Med 1988, 148:681-683.
36. Moser K.M., Fedullo P.F., LitteJohn J.K., et al. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis [published erratum appears in JAMA 1994;271(24):1908] [see comments]. JAMA 1994, 271:223-225.
37. Huisman M.V., Buller H.R., ten Cate J.W., et al. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest 1989, 95:498-502.
38. Eichinger S., Weltermann A., Minar E., et al. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. Arch Intern Med 2004, 164:92-96.
39. Carter A.M., Catto A.J., Kohler H.P., et al. Alpha-fibrinogen thr312ala polymorphism and venous thromboembolism. Blood 2000, 96:1177-1179.
40. Le Gal G., Delahousse B., Lacut K., et al. Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism. Thromb Res 2007, 121:333-338.
41. Suntharalingam J., Goldsmith K., van Marion V., et al. Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J 2008, 31:736-741.
42. Standeven K.F., Grant P.J., Carter A.M., et al. Functional analysis of the fibrinogen aalpha thr312ala polymorphism: effects on fibrin structure and function. Circulation 2003, 107:2326-2330.
43. Schulman S., Rhedin A.S., Lindmarker P., et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of anticoagulation trial study group [see comments]. N Engl J Med 1995, 332:1661-1665.
44. Wood K.E. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002, 121:877-905.
45. Elliott C.G. Pulmonary physiology during pulmonary embolism. Chest 1992, 101:163S-171S.
46. McIntyre K.M., Sasahara A.A. The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 1971, 28:288-294.
47. McIntyre K.M., Sasahara A.A. Hemodynamic alterations related to extent of lung scan perfusion defect in pulmonary embolism. J Nucl Med 1971, 12:166-170.
48. McIntyre K.M., Sasahara A.A. Correlation of pulmonary photoscan and angiogram as measures of the severity of pulmonary embolic involvement. J Nucl Med 1971, 12:732-738.
49. McIntyre K.M., Sasahara A.A. Hemodynamic and ventricular responses to pulmonary embolism. Prog Cardiovasc Dis 1974, 17:175-190.
50. Smulders Y.M. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res 2000, 48:23-33.
51. Azarian R., Wartski M., Collignon M.A., et al. Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism. J Nucl Med 1997, 38:980-983.
52. Huet Y., Lemaire F., Brun-Buisson C., et al. Hypoxemia in acute pulmonary embolism. Chest 1985, 88:829-836.
53. D'Angelo E. Lung mechanics and gas exchange in pulmonary embolism. Haematologica 1997, 82:371-374.
54. Prediletto R., Paoletti P., Fornai E., et al. Natural course of treated pulmonary embolism. Evaluation by perfusion lung scintigraphy, gas exchange, and chest roentgenogram. Chest 1990, 97:554-561.
55. Severinghaus J.W., Swenson E.W., Finley T.N., et al. Unilateral hypoventilation produced in dogs by occluding one pulmonary artery. J Appl Physiol 1961, 16:53-60.
56. Manier G., Castaing Y., Guenard H. Determinants of hypoxemia during the acute phase of pulmonary embolism in humans. Am Rev Respir Dis 1985, 132:332-338.
57. D'Alonzo G.E., Bower J.S., DeHart P., et al. The mechanisms of abnormal gas exchange in acute massive pulmonary embolism. Am Rev Respir Dis 1983, 128:170-172.
58. Chernick V., Hodson W.A., Greenfield L.J. Effect of chronic pulmonary artery ligation on pulmonary mechanics and surfactant. J Appl Physiol 1966, 21:1315-1320.
59. Bjork L., McNeil B.J. Blood flow in pulmonary and bronchial arteries in acute experimental pneumonia and pulmonary embolism. Acta Radiol 1977, 18:393-399.
60. Dalen J.E., Haffajee C.I., Alpert J.S., et al. Pulmonary embolism, pulmonary hemorrhage and pulmonary infarction. N Engl J Med 1977, 296:1431-1435.
61. Ellis F.H., Grindlay J.H., Edwards J.E. The bronchial arteries. II. Their role in pulmonary embolism and infarction. Surgery 1952, 31:167-179.
62. Schraufnagel D.E., Tsao M.S., Yao Y.T., et al. Factors associated with pulmonary infarction. A discriminant analysis study. Am J Clin Pathol 1985, 84:15-18.
63. Tsao M.S., Schraufnagel D., Wang N.S. Pathogenesis of pulmonary infarction. Am J Med 1982, 72:599-606.
64. Jandik J., Endrys J., Rehulova E., et al. Bronchial arteries in experimental pulmonary infarction: angiographic and morphometric study. Cardiovasc Res 1993, 27:1076-1083.
65. A national cooperative study. Circulation 1973, 47:II1-II108. The urokinase pulmonary embolism trial.
66. Meneveau N., Schiele F., Vuillemenot A., et al. Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction [see comments]. Eur Heart J 1997, 18:1141-1148.
67. Meneveau N., Schiele F., Metz D., et al. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up. J Am Coll Cardiol 1998, 31:1057-1063.
68. Kasper W., Konstantinides S., Geibel A., et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry [see comments]. J Am Coll Cardiol 1997, 30:1165-1171.
69. Hamel E., Pacouret G., Vincentelli D., et al. Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry. Chest 2001, 120:120-125.
70. Konstantinides S., Geibel A., Heusel G., et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002, 347:1143-1150.
71. Dalen J.E., Alpert J.S., Hirsh J. Thrombolytic therapy for pulmonary embolism: is it effective?. Is it safe? When is it indicated?. Arch Intern Med 1997, 157:2550-2556.
72. Morgenthaler T.I., Ryu J.H. Clinical characteristics of fatal pulmonary embolism in a referral hospital. Mayo Clin Proc 1995, 70:417-424.
73. Kucher N., Rossi E., De Rosa M., et al. Massive pulmonary embolism. Circulation 2006, 113:577-582.
74. Jha V.M., Lee-Llacer J., Williams J., et al. Adjunctive inferior vena cava filter placement for acute pulmonary embolism. Cardiovasc Intervent Radiol 2010, 33:739-743.
75. Rose P.S., Punjabi N.M., Pearse D.B. Treatment of right heart thromboemboli. Chest 2002, 121:806-814.
76. Donnamaria V., Palla A., Petruzzelli S., et al. Early and late follow-up of pulmonary embolism. Respiration 1993, 60:15-20.
77. Menendez R., Nauffal D., Cremades M.J. Prognostic factors in restoration of pulmonary flow after submassive pulmonary embolism: a multiple regression analysis. Eur Respir J 1998, 11:560-564.
78. Murphy M.L., Bulloch R.T. Factors influencing the restoration of blood flow following pulmonary embolization as determined by angiography and scanning. Circulation 1968, 38:1116-1126.
79. Palla A., Donnamaria V., Petruzzelli S., et al. Follow-up of pulmonary perfusion recovery after embolism. J Nucl Med Allied Sci 1986, 30:23-28.
80. Walker R.H., Goodwin J., Jackson J.A. Resolution of pulmonary embolism. Br Med J 1970, 4:135-139.
81. Wartski M., Collignon M.A. Incomplete recovery of lung perfusion after 3 months in patients with acute pulmonary embolism treated with antithrombotic agents. THESEE study group. Tinzaparin ou Heparin Standard: Evaluation dans l'Embolie Pulmonaire Study. J Nucl Med 2000, 41:1043-1048.
82. Ribeiro A., Lindmarker P., Johnsson H., et al. Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. Circulation 1999, 99:1325-1330.
83. Miller R.L., Das S., Anandarangam T., et al. Association between right ventricular function and perfusion abnormalities in hemodynamically stable patients with acute pulmonary embolism. Chest 1998, 113:665-670.
84. Dantzker D.R., Wagner P.D., Tornabene V.W., et al. Gas exchange after pulmonary thromboemoblization in dogs. Circ Res 1978, 42:92-103.
85. Wagner P.D., Laravuso R.B., Goldzimmer E., et al. Distribution of ventilation-perfusion ratios in dogs with normal and abnormal lungs. J Appl Physiol 1975, 38:1099-1109.
86. Wagner P.D., Laravuso R.B., Uhl R.R., et al. Distributions of ventilation-perfusion ratios in acute respiratory failure. Chest 1974, 65(Suppl):35S.
87. Tsang J.Y., Lamm W.J., Starr I.R., et al. Spatial pattern of ventilation-perfusion mismatch following acute pulmonary thromboembolism in pigs. J Appl Physiol 2005, 98:1862-1868.
88. Phear D. Pulmonary embolism. A study of late prognosis. Lancet 1960, 2:832-835.
89. Winebright J.W., Gerdes A.J., Nelp W.B. Restoration of blood flow after pulmonary embolism. Arch Intern Med 1970, 125:241-247.
90. Tow D.E., Wagner H.N. Recovery of pulmonary arterial blood flow in patients with pulmonary embolism. N Engl J Med 1967, 276:1053-1059.
91. Hall R.J., Sutton G.C., Kerr I.H. Long-term prognosis of treated acute massive pulmonary embolism. Br Heart J 1977, 39:1128-1134.
92. James W.S., Menn S.J., Moser K.M. Rapid resolution of a pulmonary embolus in man. West J Med 1978, 128:60-64.
93. Dalen J.E., Banas J.S., Brooks H.L., et al. Resolution rate of acute pulmonary embolism in man. N Engl J Med 1969, 280(22):1194-1199.
94. Wartski M., Collignon M.A. Incomplete recovery of lung perfusion after 3 months in patients with acute pulmonary embolism treated with antithrombotic agents. Thesee study group. Tinzaparin ou heparin standard: Evaluation dans l'embolie pulmonaire study. J Nucl Med 2000, 41:1043-1048.
95. Paraskos J.A., Adelstein S.J., Smith R.E., et al. Late prognosis of acute pulmonary embolism. N Engl J Med 1973, 289:55-58.
96. Sutton G.C., Hall R.J., Kerr I.H. Clinical course and late prognosis of treated subacute massive, acute minor, and chronic pulmonary thromboembolism. Br Heart J 1977, 39:1135-1142.
97. De Soyza N.D., Murphy M.L. Persistent post-embolic pulmonary hypertension. Chest 1972, 62:665-668.
98. Eagleton M.J., Henke P.K., Luke C.E., et al. Southern Association for Vascular Surgery William J. von Leibig Award. Inflammation and intimal hyperplasia associated with experimental pulmonary embolism. J Vasc Surg 2002, 36:581-588.
99. Yi E.S., Kim H., Ahn H., et al. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. Am J Respir Crit Care Med 2000, 162:1577-1586.
100. Blauwet L.A., Edwards W.D., Tazelaar H.D., et al. Surgical pathology of pulmonary thromboendarterectomy: a study of 54 cases from 1990 to 2001. Hum Pathol 2003, 34:1290-1298.
101. Fedullo P.F., Auger W.R., Channick R.N., et al. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 2001, 22:561-581.
102. Morris T.A., Marsh J.J., Chiles P.G., et al. Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. Am J Respir Crit Care Med 2006, 173:1270-1275.
103. Qi J., Kreutzer D.L. Fibrin activation of vascular endothelial cells. Induction of il-8 expression. J Immunol 1995, 155:867-876.
104. Martinez J., Ferber A., Bach T.L., et al. Interaction of fibrin with VE-cadherin. Ann N Y Acad Sci 2001, 936:386-405.
105. Tsakadze N.L., Zhao Z., D'Souza S.E. Interactions of intercellular adhesion molecule-1 with fibrinogen. Trends Cardiovasc Med 2002, 12:101-108.
106. Barnard J.W., Biro M.G., Lo S.K., et al. Neutrophil inhibitory factor prevents neutrophil-dependent lung injury. J Immunol 1995, 155:4876-4881.
107. Lang I., Kerr K. Risk factors for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006, 3:568-570.
108. Morris T.A., Marsh J.J., Chiles P.G., et al. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood 2009, 114:1929-1936.
109. Linenberger M.L., Kindelan J., Bennett R.L., et al. Fibrinogen bellingham: a gamma-chain R275C substitution and a beta-promoter polymorphism in a thrombotic member of an asymptomatic family. Am J Hematol 2000, 64:242-250.
110. Varma M.R., Varga A.J., Knipp B.S., et al. Neutropenia impairs venous thrombosis resolution in the rat. J Vasc Surg 2003, 38:1090-1098.
111. Myers D., Farris D., Hawley A., et al. Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. J Surg Res 2002, 108:212-221.
112. Furie B., Furie B.C., Flaumenhaft R. A journey with platelet p-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 2001, 86:214-221.
113. Andre P. P-selectin in haemostasis. Br J Haematol 2004, 126:298-306.
114. Ley K. The role of selectins in inflammation and disease. Trends Mol Med 2003, 9:263-268.
115. Inami N., Nomura S., Kikuchi H., et al. P-selectin and platelet-derived microparticles associated with monocyte activation markers in patients with pulmonary embolism. Clin Appl Thromb Hemost 2003, 9:309-316.
116. Celi A., Pellegrini G., Lorenzet R., et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A 1994, 91:8767-8771.
117. Hidari K.I., Weyrich A.S., Zimmerman G.A., et al. Engagement of P-selectin glycoprotein ligand-1 enhances tyrosine phosphorylation and activates mitogen-activated protein kinases in human neutrophils. J Biol Chem 1997, 272:28750-28756.
118. Palabrica T., Lobb R., Furie B.C., et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992, 359:848-851.
119. Thanaporn P., Myers D.D., Wrobleski S.K., et al. P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model. Surgery 2003, 134:365-371.
120. Wang L., Brown J.R., Varki A., Esko J.D. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest 2002, 110:127-136.
121. Koenig A., Norgard-Sumnicht K., Linhardt R., et al. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest 1998, 101:877-889.